A citation-based method for searching scientific literature

Lodewijk J A Toonen, Frank Rigo, Haico van Attikum, Willeke M C van Roon-Mom. Mol Ther Nucleic Acids 2017
Times Cited: 53



Y Kawaguchi, T Okamoto, M Taniwaki, M Aizawa, M Inoue, S Katayama, H Kawakami, S Nakamura, M Nishimura, I Akiguchi. Nat Genet 1994
Times Cited: 1440




List of shared articles



Times cited



Pathogenesis of SCA3 and implications for other polyglutamine diseases.
Hayley S McLoughlin, Lauren R Moore, Henry L Paulson. Neurobiol Dis 2020
33

Antisense oligonucleotide therapeutics in neurodegenerative diseases: the case of polyglutamine disorders.
Ana C Silva, Diana D Lobo, Inês M Martins, Sara M Lopes, Carina Henriques, Sónia P Duarte, Jean-Cosme Dodart, Rui Jorge Nobre, Luis Pereira de Almeida. Brain 2020
19

Spinocerebellar ataxia: an update.
Roisin Sullivan, Wai Yan Yau, Emer O'Connor, Henry Houlden. J Neurol 2019
56

Machado-Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy.
Carlos A Matos, Luís Pereira de Almeida, Clévio Nóbrega. J Neurochem 2019
39

Pathogenic mechanisms underlying spinocerebellar ataxia type 1.
Leon Tejwani, Janghoo Lim. Cell Mol Life Sci 2020
1

Gene Therapy for Neurodegenerative Diseases: Slowing Down the Ticking Clock.
Raygene Martier, Pavlina Konstantinova. Front Neurosci 2020
7


The Role of MicroRNAs in Spinocerebellar Ataxia Type 3.
Sybille Krauss, Bernd O Evert. J Mol Biol 2019
5

PolyQ-expanded ataxin-3 protein levels in peripheral blood mononuclear cells correlate with clinical parameters in SCA3: a pilot study.
Kathrin Gonsior, Gabriele Anna Kaucher, Patrik Pelz, Dorothea Schumann, Melanie Gansel, Sandra Kuhs, Thomas Klockgether, Sylvie Forlani, Alexandra Durr, Stefan Hauser,[...]. J Neurol 2021
2


Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease.
Raygene Martier, Marina Sogorb-Gonzalez, Janice Stricker-Shaver, Jeannette Hübener-Schmid, Sonay Keskin, Jiri Klima, Lodewijk J Toonen, Stefan Juhas, Jana Juhasova, Zdenka Ellederova,[...]. Mol Ther Methods Clin Dev 2019
19

In Vivo Molecular Signatures of Cerebellar Pathology in Spinocerebellar Ataxia Type 3.
Maria do Carmo Costa, Maria Radzwion, Hayley S McLoughlin, Naila S Ashraf, Svetlana Fischer, Vikram G Shakkottai, Patrícia Maciel, Henry L Paulson, Gülin Öz. Mov Disord 2020
3

Removal of the Polyglutamine Repeat of Ataxin-3 by Redirecting pre-mRNA Processing.
Craig S McIntosh, May Thandar Aung-Htut, Sue Fletcher, Steve D Wilton. Int J Mol Sci 2019
6

Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias.
Ronald A M Buijsen, Lodewijk J A Toonen, Sarah L Gardiner, Willeke M C van Roon-Mom. Neurotherapeutics 2019
39

Recent therapeutic prospects for Machado-Joseph disease.
Maria do Carmo Costa. Curr Opin Neurol 2020
0